Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -23.08%. A quarter ago, it was expected that this producer of custom industrial enzymes would post a loss of $0.17 per share when it actually produced a loss of $0.16, delivering a surprise of 5.88%. Over the last four quarters, ...